Pfizer Expands Cancer Platform With High-Priced Medivation Acquisition
August 22, 2016 at 12:59 PM EDT
Despite the high price paid, we don't expect any major changes in Pfizer's fair value estimate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|